AbCellera Posts $10.6 Million in Q3 2026 Revenue, $0.13 Net Loss Per Share

John Kim

1 min read

Add as a preferred source on Google

AbCellera Posts $10.6 Million in Q3 2026 Revenue, $0.13 Net Loss Per Share

The net loss was $0.13 per share on both a basic and diluted basis. AbCellera released its results Nov. 9.

By John Kim

Published Nov 10, 2026, 6:04 PM EST

A glass antibody model rests beside a closed report / TokenPost.ai

AbCellera Biologics Inc. posted $10.6 million in revenue and a net loss of $0.13 per share for Q3 2026, the two headline figures in its latest quarterly results.

The per-share loss was $0.13 on both a basic and diluted basis. AbCellera released its Q3 2026 results Nov. 9.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.